170 related articles for article (PubMed ID: 21430353)
1. The Philadelphia chromosome: celebration of the 50th anniversary of its discovery.
Knutsen T
J Assoc Genet Technol; 2011; 37(1):5-10. PubMed ID: 21430353
[TBL] [Abstract][Full Text] [Related]
2. Philadelphia Chromosome Symposium: commemoration of the 50th anniversary of the discovery of the Ph chromosome.
Chandra HS; Heisterkamp NC; Hungerford A; Morrissette JJ; Nowell PC; Rowley JD; Testa JR
Cancer Genet; 2011 Apr; 204(4):171-9. PubMed ID: 21536234
[TBL] [Abstract][Full Text] [Related]
3. XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on september 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference Center.
Muggia FM; Peters GJ; Landolph JR
Mol Cancer Ther; 2009 May; 8(5):992-9. PubMed ID: 19417150
[TBL] [Abstract][Full Text] [Related]
4. Chronic myelocytic leukemia--Part I: History, clinical presentation, and molecular biology.
Randolph TR
Clin Lab Sci; 2005; 18(1):38-48. PubMed ID: 15747785
[TBL] [Abstract][Full Text] [Related]
5. Discovery of the Philadelphia chromosome: a personal perspective.
Nowell PC
J Clin Invest; 2007 Aug; 117(8):2033-5. PubMed ID: 17671636
[TBL] [Abstract][Full Text] [Related]
6. Selected contributions to neurology by Philadelphia neurologists since 1980.
Asbury AK; Sperling MR; Aguirre GK; Liu GT
Rev Neurol Dis; 2010; 7(4):140-9. PubMed ID: 21206430
[TBL] [Abstract][Full Text] [Related]
7. [History of chronic myeloid leukemia: a paradigm in the treatment of cancer].
Gonon-Demoulian R; Goldman JM; Nicolini FE
Bull Cancer; 2014 Jan; 101(1):56-67. PubMed ID: 24491668
[TBL] [Abstract][Full Text] [Related]
8. [Molecular construction of Philadelphia chromosome and its relation to the clinical features].
Kamada N; Tanaka K; Asou H
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1098-105. PubMed ID: 2053768
[TBL] [Abstract][Full Text] [Related]
9. The history of myeloproliferative disorders: before and after Dameshek.
Tefferi A
Leukemia; 2008 Jan; 22(1):3-13. PubMed ID: 17882283
[TBL] [Abstract][Full Text] [Related]
10. The road from The Microbial world to Microbe.
Schaechter M; Ingraham JL; Neidhardt FC
Int Microbiol; 2007 Sep; 10(3):153-6. PubMed ID: 18075996
[TBL] [Abstract][Full Text] [Related]
11. A report from the American Academy of Neurology 2014 Annual Meeting (April 26-May 3 - Philadelphia, Pennsylvania, USA).
Rabasseda X
Drugs Today (Barc); 2014 Jun; 50(6):445-60. PubMed ID: 24983592
[TBL] [Abstract][Full Text] [Related]
12. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
Dobrić I
Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
[TBL] [Abstract][Full Text] [Related]
13. Stem cells in prostate cancer initiation and progression.
Lawson DA; Witte ON
J Clin Invest; 2007 Aug; 117(8):2044-50. PubMed ID: 17671638
[TBL] [Abstract][Full Text] [Related]
14. 50th anniversary of the discovery of reverse transcriptase.
Coffin JM
Mol Biol Cell; 2021 Jan; 32(2):91-97. PubMed ID: 33448895
[TBL] [Abstract][Full Text] [Related]
15. Peter C. Nowell (1928-2016).
Greene MI; Moore JS
Science; 2017 Mar; 355(6328):913. PubMed ID: 28254903
[No Abstract] [Full Text] [Related]
16. ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 4: From Discovery to Cure: The Future of Therapeutics.
Di Mauro G; Dondi A; Giangreco G; Hogrebe A; Louer E; Magistrati E; Mullari M; Turon G; Verdurmen W; Xicoy Cortada H; Zivanovic S
Med Sci (Basel); 2018 May; 6(2):. PubMed ID: 29843430
[TBL] [Abstract][Full Text] [Related]
17. [Review: progress of cytogenetics in hematopoietic malignancies].
Kamada N; Takechi M; Kudo S
Nihon Rinsho; 1992 Jun; 50(6):1267-73. PubMed ID: 1518144
[TBL] [Abstract][Full Text] [Related]
18. Spectral Karyotyping (SKY) of Hematologic Malignancies.
Hilgenfeld E; Padilla-Nash H; Schröck E; Ried T; Haas OA; Serve H
Methods Mol Med; 2001; 55():65-79. PubMed ID: 21312104
[TBL] [Abstract][Full Text] [Related]
19. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
20. Fox Chase Network: Fox Chase Cancer Center's community hospital affiliation program.
Higman SA; McKay FJ; Engstrom PF; O'Grady MA; Young RC
Oncologist; 2000; 5(4):329-35. PubMed ID: 10965001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
